Viridian Therapeutics
VRDN
VRDN
229 hedge funds and large institutions have $3.36B invested in Viridian Therapeutics in 2025 Q4 according to their latest regulatory filings, with 77 funds opening new positions, 85 increasing their positions, 45 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
36% more funds holding
Funds holding: 169 → 229 (+60)
8% more funds holding in top 10
Funds holding in top 10: 12 → 13 (+1)
1.15% less ownership
Funds ownership: 114.13% → 112.97% (-1.2%)
Holders
229
Holding in Top 10
13
Calls
$1.51M
Puts
$728K
Top Buyers
| 1 | +$120M | |
| 2 | +$58.6M | |
| 3 | +$43.3M | |
| 4 |
Morgan Stanley
New York
|
+$42.4M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$41.1M |
Top Sellers
| 1 | -$81.1M | |
| 2 | -$78.3M | |
| 3 | -$69.1M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$47.8M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$32M |
